China SXT Pharmaceuticals, Inc.
SXTC
$3.92
$0.6218.79%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 1.34M | 1.54M | 1.64M | 1.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 1.34M | 1.54M | 1.64M | 1.74M |
| Cost of Revenue | 889.40K | 1.05M | 1.20M | 1.29M | 1.37M |
| Gross Profit | 248.80K | 291.60K | 334.40K | 350.90K | 367.40K |
| SG&A Expenses | 7.37M | 8.04M | 8.72M | 5.88M | 3.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.26M | 9.09M | 9.92M | 7.17M | 4.42M |
| Operating Income | -7.12M | -7.75M | -8.38M | -5.53M | -2.68M |
| Income Before Tax | -6.21M | -7.54M | -8.87M | -6.09M | -3.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.21 | -7.54 | -8.87 | -6.09 | -3.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.21M | -7.54M | -8.87M | -6.09M | -3.30M |
| EBIT | -7.12M | -7.75M | -8.38M | -5.53M | -2.68M |
| EBITDA | -7.05M | -7.69M | -8.34M | -5.47M | -2.60M |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |